These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 17197854

  • 1. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure.
    Hentschel T, Yin N, Riad A, Habbazettl H, Weimann J, Koster A, Tschope C, Kuppe H, Kuebler WM.
    Anesthesiology; 2007 Jan; 106(1):124-31. PubMed ID: 17197854
    [Abstract] [Full Text] [Related]

  • 2. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhaled milrinone: a new alternative in cardiac surgery?
    Denault AY, Lamarche Y, Couture P, Haddad F, Lambert J, Tardif JC, Perrault LP.
    Semin Cardiothorac Vasc Anesth; 2006 Dec; 10(4):346-60. PubMed ID: 17200091
    [Abstract] [Full Text] [Related]

  • 9. Inhaled milrinone attenuates experimental acute lung injury.
    Bueltmann M, Kong X, Mertens M, Yin N, Yin J, Liu Z, Koster A, Kuppe H, Kuebler WM.
    Intensive Care Med; 2009 Jan; 35(1):171-8. PubMed ID: 18972099
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide.
    McNamara PJ, Shivananda SP, Sahni M, Freeman D, Taddio A.
    Pediatr Crit Care Med; 2013 Jan; 14(1):74-84. PubMed ID: 23132395
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV, Carere RG, Webb JG, Cook RC, D'yachkova Y, Abel JG, Ignaszewski AP.
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
    Kundra TS, Prabhakar V, Kaur P, Manjunatha N, Gandham R.
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2123-2129. PubMed ID: 30098861
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass.
    Lamarche Y, Malo O, Thorin E, Denault A, Carrier M, Roy J, Perrault LP.
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):83-92. PubMed ID: 15999045
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.